Physician
Internal Medicine
Dr. Harris H. McIlwain, MD
|
|
Give Review
Harris McIlwain works in the field of Internal Medicine. He graduated from Emory University School of Medicine. Emory University School of Medicine has a rank of 23 in research and a 42 in primary care He received 4 awards: "Top MD", "Fellow", "Fellow (FACR)" and "Super Doctor". Harris McIlwain is a published MD. He published 76 publications, including: 'Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study.' He is registered with Medicare.
Publications
- Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
- Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management.
- Biochemistry and neurochemistry in the 1800s: their origins in comparative animal chemistry.
- How neurochemistry regained its specific biological components: experimental and cognitive advance, 1935-1955.
- Contributions to neurochemical knowledge considered ecologically.
- 5''-Adenine mononucleotides in synaptosomal preparations from guinea pig neocortex: their change on incubation, superfusion and stimulation.
- Centrally-acting drugs and related compounds examined for action on output of adenine derivatives from superfused tissues of the brain.
- The metabolism of adenine derivatives in different parts of the brain of the rat, and their release from hypothalamic preparations on excitation.
- The Second Thudichum Lecture. Cerebral isolates and neurochemical Discovery.
- Redistribution of adenine derivatives among subCellular fractions from guinea pig neocortical tissues, on incubation in vitro.
- Persistence of increased histone kinase activity of neocortical tissues in relation to excitation and to adenosine 3'':5''-cyclic monophosphate.
- Cellular site and state combination of the adenosine 3'':5''-cyclic monophosphate persisting after excitation of cerebral tissues.
- Adenosine 3'':5''-cyclic monophosphate in nerve-terminal fractions from neocortical tissues: its augmentation by a post-stimulation process [proceedings].
- Adenosine as a constituent of the brain and of isolated cerebral tissues, and its relationship to the generation of adenosine 3'':5''-cyclic monophosphate.
- The persistence, translocation and metabolism of adenosine 3'':5''-cyclic monophosphate generated in isolated cerebral tissues by electrical excitation.
- Transport of adenine derivatives in tissues of the brain.
- An extended messenger-role in the brain for cyclic AMP.
- Actions of neurohumoral agents and cerebral metabolities on output of adenine derivatives from superfused tissues of the brain.
- Synaptic mediators and the structuring of cerebral activity.
- Extended roles in the brain for second-messenger systems.
- Limited plasmapheresis in rheumatoid Arthritis with vasculitis.
- Neurochemistry and related terms: their introduction and acceptance.
- Adenosine modifies colchicine-uptake into tissues from the mammalian brain.
- Interaction between adenosine generated endogenously in neocortical tissues, and homocysteine and its thiolactone.
- Colchicine-binding measurements of tubulin in variously sampled and incubated tissues from the mammalian brain.
- Assay-guided isolation of naturally-occurring neuroactive substances.
- Adenosine in cerebral homeostatic role: appraisal through actions of homocysteine, colchicine, and dipyridamole.
- The origin and use of the terms competitive and non-competitive in interactions among chemical substances in biological systems.
- In the beginning: to celebrate 20 years of the International Society for Neurochemistry (ISN).
- Intra-articular orgotein in osteoArthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison.
- An estradiol matrix transdermal system for the prevention of postmenopausal bone loss.
- Effect of specific COX-2 inhibition in osteoArthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib OsteoArthritis Pilot S...
- An open-label extension study of alendronate treatment in elderly women with osteoporosis.
- Comparative study of alendronate versus etidronate for the treatment of Paget's Disease of bone.
- Erythrocyte transketolase activity in suspected cases of Leigh''s Disease, or subacute necrotising encephalomyelopathy.
- Erythrocyte transketolase activity in the Wernicke-Korsakoff Syndrome.
- The binding of [3H]adenosine to synaptosomal and other preparations from the mammalian brain.
- Wernicke-Korsakoff Syndrome in monozygotic twins: a biochemical peculiarity.
- Neurochemistry and Sherrington''s enchanted loom.
- Adenosine-binding to cerebral preparations in interpretation of adenosine activation of adenosine 3'':5''-cyclic monophosphate formation [proceedings].
- The flow of thought and the flow of substance in the brain.
- Cyclic AMP-binding capacities and histone kinase activation in subCellular components of neocortical tissue. Differential responses to three neurohumoural agents.
- Pursuing the actions of psychotropic drugs: receptor sites and endogenous cerebral programmes.
- An interpretation of the endogenous, spontaneously-generated activities of the brain and of cerebral subsystems.
- Tetrodotoxin on the sodium and other ions of cerebral tissues, excited electrically and with glutamate.
- Amino acid distribution and incorporation into proteins in isolated, electrically-stimulated cerebral tissues.
- A flow system for the superfusion and stimulation of isolated mammalian tissues.
- Calcium content and exchange in neocortical tissues during the cation movements induced by glutamates.
- Superfused cerebral tissues in hypoxia: neurotransmitter and amino acid retention; labile constituents and Response to excitation.
- Metabolism of ( 14 C)adenine and derivatives by cerebral tissues, superfused and electrically stimulated.
- Release of adenine derivatives on electrical stimulation of superfused tissues from the brain.
- Glutamate, Calcium ion-chelating agents and the sodium and potassium ion contents of tissues from the brain.
- Consequences of cerebral hypoxia examined at tissue-metabolic level.
- Release of ( 14 C)adenine derivatives from isolated subsystems of the guinea pig brain: actions of electrical stimulation and of papaverine.
- Regulatory significance of the release and action of adenine derivatives in cerebral systems.
- Rat cerebral-cortex adenosine deaminase activity and its subCellular distribution.
- Output of ( 14 C)adenine derivatives on electrical excitation of tissues from the brain: Calcium ion-sensitivity and an accompanying re-uptake process.
- Metabolic adaptation in the brain.
- Stimulation of piriform- and neo-cortical tissues in an in vitro flow-system: metabolic properties and release of putative neurotransmitters.
- The effect of electrical stimulation upon the accumulation of adenosine 3'',5''-phosphate in isolated cerebral tissue.
- Uptake and relase of (14C)adenine derivatives at beds of mammalian cortical synaptosomes in a superfusion system.
- Output of (14C)adenine nucleotides and their derivatives from cerebral tissues. Tetrodotoxin-resistant and Calcium ion-requiring components.
- SubCellular localization of (14C)adenine derivatives newly-formed in cerebral tissues and the effects of electrical excitation.
- Tests of excitability applied to isolated tissues from the brain.
- Types of metabolic adaptation in the brain.
- Adenine derivatives as neurohumoral agents in the brain. The quantities liberated on excitation of superfused cerebral tissues.
- Amino acid production and translocation in incubated and superfused tissues from the brain.
- Fenoprofen Calcium versus aspirin in the treatment of acute inflammatory soft-tissue injuries.
- Flare during drug withdrawal as a method to support efficacy in rheumatoid Arthritis: amiprilose hydrochloride as an example in a double blind, randomized study.
- Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-Response study (with a commentary by Michael Weintraub).
- Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes.
- Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled ex...
- A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid Arthritis.
- Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving Chronic glucocorticoid therapy.
- Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoArthritis pain: a one-year study.
Schools
Emory University School Of Medicine
Grady Memorial Hospital
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Adhesive Capsulitis
- Amyloidosis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Geriatric Medicine
- Rheumatology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- AvMed
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Wellpath Preferred PPO
- Employer Group Open Access HMO
- Employer Group PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Preferred PPO
- Select HMO
- Tampa Bay HUMx HMOx
- Medicaid
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- National Elevator
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
- WellCare
Awards
- Top MD
- Fellow
- Fellow (FACR)
- Super Doctor
Education
-
Emory University -
Emory University School of Medicine
Hospital
-
Florida Hospital
Drug Facts
| NPI NUMBER | 1306958350 | |
| NPPES Provider LastName | MCILWAIN | |
| NPPES Provider FirstName | HARRIS | |
| NPPES Provider ZIPCode | 336147117 | |
| NPPES Provider State | FL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 17194.0 | |
| Distinct Opioid Count | 10.0 | |
| Opioid Claim Count | 943.0 | |
| Percent Opioid Claims | 5.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306958350 |
| Last Name Of The Provider | MCILWAIN |
| First Name Of The Provider | HARRIS |
| View All |
Similar Doctors
|
|
Dr. Kathryn Corrigan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert Tawil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose P. Cariaga, MD |
|
|
Dr. Brad Bjornstad, MD |
|
|
Dr. VanEssa Veve, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Claudio V. Bocado, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seema S. Verma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel C. Silverfield, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis K. Ledford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seyed A. Zarabadi, DO |
|
|
Dr. Leni E. Kramer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchel Seleznick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir Agha, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura M. Cruse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohan Chawla, MD |